The glucose transporter PfHT1 is an antimalarial target of the HIV protease inhibitor lopinavir

Authors

Thomas E. Kraft, Washington University School of Medicine in St. Louis
Christopher Armstrong, Washington University School of Medicine in St. Louis
Monique R. Heitmeier, Washington University School of Medicine in St. Louis
Audrey R. Odom, Washington University School of Medicine in St. Louis
Paul W. Hruz, Washington University School of Medicine in St. Louis

Journal

Antimicrobial Agents and Chemotherapy

Publication Date

2015

Volume

59

Issue

10

Inclusive Pages

6203-6209

Document Type

Open Access Publication

DOI

10.1128/AAC.00899-15

Rights and Permissions

Kraft TE, Armstrong C, Heitmeier MR, Odom AR, Hruz PW. 2015. The glucose transporter PfHT1 is an antimalarial target of the HIV protease inhibitor lopinavir. Antimicrob Agents Chemother 59:6203–6209. doi:10.1128/AAC.00899-15.

Recommended Citation

Kraft, Thomas E.; Armstrong, Christopher; Heitmeier, Monique R.; Odom, Audrey R.; and Hruz, Paul W., "The glucose transporter PfHT1 is an antimalarial target of the HIV protease inhibitor lopinavir." Antimicrobial Agents and Chemotherapy. 59, 10. 6203-6209. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/4250